Fibrinogen Panel
Also known as: FIB PAN
Use
The Fibrinogen Panel is utilized to assist in diagnosing dysfibrinogenemia, a rare inherited bleeding disorder that affects the fibrinogen protein responsible for blood clot formation. Evaluating functional levels and antigen levels of fibrinogen, along with the Ag/Functional Ratio, the test aids in the identification of qualitative fibrinogen abnormalities that could lead to abnormal bleeding or thrombotic events.
Special Instructions
For accurate results, ensure proper specimen collection and handling. It is crucial that the collected specimen remains frozen, as deviations in the specimen temperature can affect the test outcomes. Special attention should be paid to submitting separate specimens if multiple tests are ordered simultaneously.
Limitations
This test cannot detect all causes of abnormal fibrinogen levels and is primarily effective in identifying dysfibrinogenemia. Conditions like hypofibrinogenemia or afibrinogenemia may not be fully elucidated through this test alone. Other disorders affecting hemostasis should also be considered when clinical symptoms do not correlate with the test results.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 3255-7
- 3256-5
- 31158-9
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
2 mL
Minimum Volume
1.5 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Collect using a Lt. blue (sodium citrate) tube. Ensure transfer to a transport tube after achieving platelet-poor plasma.
Storage Instructions
Store and transport the specimen in a frozen state. Room temperature and refrigeration are not acceptable.
Causes for Rejection
Serum, EDTA plasma, clotted, grossly lipemic or hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 4 hours |
| Refrigerated | Unacceptable |
| Frozen | 1 month |